Effects of combined therapy of Xuezhikang Capsule and Valsartan on hypertensive left ventricular hypertrophy and heart rate turbulence

Chinese Journal of Integrative Medicine

Volumn 16, Issue 2, 2010, Pages 114-118

  Gong, Chun ^a   Huang, Shao Lie ^a   Huang, Jian Feng ^a   Zhang, Zhi Fang ^b   Luo, Ming ^a   Zhao, Yu ^a   Jiang, Xiao Jie ^a  

^a NANCHANG UNIVERSITY   (China)

^b LINYI PEOPLE'S HOSPITAL   (China)

Author keywords

Heart rate turbulence; Hypertension; Left ventricular hypertrophy; Valsartan; Xuezhikang Capsule

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; VALSARTAN; XUEZHIKANG;

ARTICLE; CHOLESTEROL BLOOD LEVEL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; ECHOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART RATE; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

ADMINISTRATION, ORAL; AGED; ANTIHYPERTENSIVE AGENTS; ANTILIPEMIC AGENTS; ARRHYTHMIAS, CARDIAC; CAPSULES; COMBINED MODALITY THERAPY; DRUG COMBINATIONS; DRUGS, CHINESE HERBAL; FEMALE; HEART RATE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; INTEGRATIVE MEDICINE; MALE; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; TETRAZOLES; TREATMENT OUTCOME; VALINE;

EID: 77954488997     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-010-0114-z     Document Type: Article

References (14)

1. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991;114:345-352.
2. Takemono M , Node K, Nakagami H. Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. J Clin Invest 2001;108:1429-1437.
3. Ye P, Sheng L, Zhang C, Liu Y. Atorvastatin attenuating down-regulation of peroxisome proliferator-activated receptor gamma in preventing cardiac hypertrophy of rats in vitro and in vivo. J Pharm Pharm Sci 2006;9:365-375.
4. World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO), International Society of Hypertension (ISH) statement on management of hypertension (Guidelines and recommendations). J Hypertens 2003;21:1983-1992.
5. Morley-davies A, Dargie HJ, Cobbe SM, Schneider R, Schmidt G. Heart rate turbulence: a novel holter derived measure and mortality in chronic heart failure. Eur Heart J 2000;21:408-416.
6. Guo JH. Heart rate turbulence. J Clin Electrocardiol 2003;24:49-54.
7. De Simone G, Devereux RB, Camargo MJ, Wallerson DC, Laragh JH. Midwall left ventricular performance in saltloaded Dahl rats: effect of AT1 angiotensin II inhibition. J Hypertens 1996;13:1808-1824.
8. Tedesco MA, Ratti G, Aquino D, Limongelli G, di Salvo G, Mennella S, et al. Effects of valsartan on hypertension and left ventricular mass: a long-term study. J Hum Hypertens 1998;24:505-510. (Pubitemid 28431003)
9. Dechend R, Fiebeler A, Park JK, Muller DN, Theuer J, Mervaala E, et al. Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3- methylgutaryl coenzyme A reductase inhibitor. Circulation 2001;104:576-581. (Pubitemid 32738128)
10. Indolfi C, Di LE, Perrino C, Stingone AM, Curcio A, Torella D, et al. Hydroxymethylglutaryl coenzyme A reductase inhibitor Xuezhikang Capsules prevents cardiac hypertrophy induced by pressure overload and inhibits p21 ras activation. Circulation 2002;106:2118-2244.
11. Lin LY, Lai LP, Lin JL, Du CC, Shau WY, Chan HL, et al. Tight mechanism correlation between heart rate turbulence and baroreflex sensitivity: sequential autonomic blockade analysis. J Cardiovasc Electrophysiol 2002;13:427.
12. Marine JE, Watanabe MA, Smith TW, Monahan KM. Effect of atropine on heart rate turbulence. Am J Cardiol 2002;89:767.
13. Poreba R, Derkacz A, Silber M, Andrzejak R. Assessment of cardiac arrhythmias in patients suffering from essential hypertension. Pol Arch Med Wewn 2004;111:183-189.
14. Kawasaki T, Azuma A, Asada S, Hadase M, Kamitani T, Kawasaki S, et al. Heart rate turbulence and clinical prognosis in hypertrophic cardiomyopathy and myocardial infarction. Circ J 2003;677:601.